{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:30:04Z","timestamp":1789615804257,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2021-I2M-1-008"],"award-info":[{"award-number":["2021-I2M-1-008"]}]},{"name":"National Key Research and Development Program of China","award":["2024YFA1109101"],"award-info":[{"award-number":["2024YFA1109101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-026-02485-8","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:45:24Z","timestamp":1773398724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Immune-Phenotyping of Peripheral Lymphocytes in Coronary Artery Disease Reveals Potential Roles of Effector Memory and PD-1\u207a CD4\u207a T Cells"],"prefix":"10.1007","volume":"49","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fada","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"2485_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112906","volume":"23","author":"Michael Y. Henein","year":"2022","unstructured":"Henein, Michael Y.., Sergio Vancheri, Giovanni Longo, and Federico Vancheri. 2022. The role of inflammation in cardiovascular disease. International Journal of Molecular Sciences 23: 12906. https:\/\/doi.org\/10.3390\/ijms232112906.","journal-title":"International Journal of Molecular Sciences"},{"key":"2485_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"Amir Ajoolabady","year":"2024","unstructured":"Ajoolabady, Amir, Domenico Pratico, Ling Lin, Christos S.. Mantzoros, Suhad Bahijri, Jaakko Tuomilehto, and Jun Ren. 2024. Inflammation in atherosclerosis: Pathophysiology and mechanisms. Cell Death & Disease 15: 817. https:\/\/doi.org\/10.1038\/s41419-024-07166-8.","journal-title":"Cell Death & Disease"},{"key":"2485_CR3","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2020.08.011","volume":"76","author":"Brendan M. Everett","year":"2020","unstructured":"Everett, Brendan M.., Jean G.. MacFadyen, Tom Thuren, Peter Libby, Robert J.. Glynn, and Paul M.. Ridker. 2020. Inhibition of interleukin-1\u03b2 and reduction in atherothrombotic cardiovascular events in the CANTOS trial. Journal of the American College of Cardiology 76: 1660\u20131670. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.011.","journal-title":"Journal of the American College of Cardiology"},{"key":"2485_CR4","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","volume":"77","author":"Kaspar Broch","year":"2021","unstructured":"Broch, Kaspar, Anne Kristine Anstensrud, Sindre Woxholt, Kapil Sharma, Ingvild Maria T\u00f8llefsen, Bj\u00f8rn. Bendz, Svend Aakhus, et al. 2021. Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 77: 1845\u20131855. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.049.","journal-title":"Journal of the American College of Cardiology"},{"key":"2485_CR5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"Stefan M. Nidorf","year":"2020","unstructured":"Nidorf, Stefan M.., Aernoud T. L.. Fiolet, Arend Mosterd, John W.. Eikelboom, Astrid Schut, Tjerk S. J.. Opstal, Salem H. K.. The, et al. 2020. Colchicine in patients with chronic coronary disease. New England Journal of Medicine 383: 1838\u20131847. https:\/\/doi.org\/10.1056\/NEJMoa2021372.","journal-title":"New England Journal of Medicine"},{"key":"2485_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1001\/jamacardio.2024.2298","volume":"9","author":"Jasmine Melissa Madsen","year":"2024","unstructured":"Madsen, Jasmine Melissa, Thomas Engstr\u00f8m, Laust Emil Roelsgaard. Obling, Yan Zhou, Lars Nepper-Christensen, Rasmus Paulin Beske, Niels Grove Vejlstrup, et al. 2024. Prehospital pulse-dose glucocorticoid in ST-segment elevation myocardial infarction: The PULSE-MI randomized clinical trial. JAMA Cardiology 9: 882\u2013891. https:\/\/doi.org\/10.1001\/jamacardio.2024.2298.","journal-title":"JAMA Cardiology"},{"key":"2485_CR7","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","volume":"142","author":"David C. Tong","year":"2020","unstructured":"Tong, David C.., Stephen Quinn, Arthur Nasis, Chin Hiew, Philip Roberts-Thomson, Heath Adams, Rumes Sriamareswaran, et al. 2020. Colchicine in patients with acute coronary syndrome: The Australian COPS randomized clinical trial. Circulation 142: 1890\u20131900. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050771.","journal-title":"Circulation"},{"key":"2485_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"Payel Roy","year":"2022","unstructured":"Roy, Payel, Marco Orecchioni, and Klaus Ley. 2022. How the immune system shapes atherosclerosis: Roles of innate and adaptive immunity. Nature Reviews. Immunology 22: 251\u2013265. https:\/\/doi.org\/10.1038\/s41577-021-00584-1.","journal-title":"Nature Reviews. Immunology"},{"key":"2485_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01840-1","volume":"9","author":"Runkai Chen","year":"2024","unstructured":"Chen, Runkai, Hongrui Zhang, Botao Tang, Yukun Luo, Yufei Yang, Xin Zhong, Sifei Chen, Xinjie Xu, Shengkang Huang, and Canzhao Liu. 2024. Macrophages in cardiovascular diseases: Molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy 9: 130. https:\/\/doi.org\/10.1038\/s41392-024-01840-1.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2485_CR10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","volume":"17","author":"Ryosuke Saigusa","year":"2020","unstructured":"Saigusa, Ryosuke, Holger Winkels, and Klaus Ley. 2020. T cell subsets and functions in atherosclerosis. Nature Reviews. Cardiology 17: 387\u2013401. https:\/\/doi.org\/10.1038\/s41569-020-0352-5.","journal-title":"Nature Reviews. Cardiology"},{"key":"2485_CR11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/eurheartj\/ehy714","volume":"40","author":"Tom T. P. Seijkens","year":"2019","unstructured":"Seijkens, Tom T. P.., Kikkie Poels, Svenja Meiler, Claudia M.. van Tiel, Pascal J. H.. Kusters, Myrthe Reiche, Dorothee Atzler, et al. 2019. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8\u2009+\u2009T cell-mediated macrophage death. European Heart Journal 40: 372\u2013382. https:\/\/doi.org\/10.1093\/eurheartj\/ehy714.","journal-title":"European Heart Journal"},{"key":"2485_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00018-015-2080-2","volume":"73","author":"Charlotte Spitz","year":"2016","unstructured":"Spitz, Charlotte, Holger Winkels, Christina B\u00fcrger, Christian Weber, Esther Lutgens, G\u00f6ran.K. Hansson, and Norbert Gerdes. 2016. Regulatory T cells in atherosclerosis: Critical immune regulatory function and therapeutic potential. Cellular and Molecular Life Sciences 73: 901\u2013922. https:\/\/doi.org\/10.1007\/s00018-015-2080-2.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"2485_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","volume":"124","author":"Dennis Wolf","year":"2019","unstructured":"Wolf, Dennis, and Klaus Ley. 2019. Immunity and inflammation in atherosclerosis. Circulation Research 124: 315\u2013327. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313591.","journal-title":"Circulation Research"},{"key":"2485_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/ATVBAHA.113.302667","volume":"34","author":"Polyxeni T. Mantani","year":"2014","unstructured":"Mantani, Polyxeni T.., Irena Ljungcrantz, Linda Andersson, Ragnar Alm, Bo. Hedblad, Harry Bj\u00f6rkbacka, Jan Nilsson, and Gunilla Nordin Fredrikson. 2014. Circulating CD40\u2009+\u2009and CD86\u2009+\u2009B cell subsets demonstrate opposing associations with risk of stroke. Arteriosclerosis, Thrombosis, and Vascular Biology 34: 211\u2013218. https:\/\/doi.org\/10.1161\/ATVBAHA.113.302667.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2485_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvu016","volume":"102","author":"Ahrathy Selathurai","year":"2014","unstructured":"Selathurai, Ahrathy, Virginie Deswaerte, Peter Kanellakis, Peter Tipping, Ban-Hock. Toh, Alex Bobik, and Tin Kyaw. 2014. Natural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanisms. Cardiovascular Research 102: 128\u2013137. https:\/\/doi.org\/10.1093\/cvr\/cvu016.","journal-title":"Cardiovascular Research"},{"key":"2485_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"Jinfang Zhu","year":"2008","unstructured":"Zhu, Jinfang, and William E.. Paul. 2008. CD4 T cells: Fates, functions, and faults. Blood 112: 1557\u20131569. https:\/\/doi.org\/10.1182\/blood-2008-05-078154.","journal-title":"Blood"},{"key":"2485_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/s41590-023-01510-4","volume":"24","author":"Marco K\u00fcnzli","year":"2023","unstructured":"K\u00fcnzli, Marco, and David Masopust. 2023. CD4\u2009+\u2009T cell memory. Nature Immunology 24: 903\u2013914. https:\/\/doi.org\/10.1038\/s41590-023-01510-4.","journal-title":"Nature Immunology"},{"key":"2485_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/44385","volume":"401","author":"F Sallusto","year":"1999","unstructured":"Sallusto, F., D. Lenig, R. F\u00f6rster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708\u2013712. https:\/\/doi.org\/10.1038\/44385","journal-title":"Nature"},{"key":"2485_CR19","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1126\/science.1058867","volume":"291","author":"D Masopust","year":"2001","unstructured":"Masopust, D., V. Vezys, A.L. Marzo, and L. Lefran\u00e7ois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science (New York, N.Y.) 291: 2413\u20132417. https:\/\/doi.org\/10.1126\/science.1058867.","journal-title":"Science (New York, N.Y.)"},{"key":"2485_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/JAHA.111.000125","volume":"1","author":"Enrico Ammirati","year":"2012","unstructured":"Ammirati, Enrico, Domenico Cianflone, Viviana Vecchio, Michela Banfi, Anna C. Vermi, Monica De Metrio, and Liliana Grigore et al. 2012. Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. Journal of the American Heart Association 1:27\u201341. https:\/\/doi.org\/10.1161\/JAHA.111.000125","journal-title":"Journal of the American Heart Association"},{"key":"2485_CR21","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"Dawn M Fernandez","year":"2019","unstructured":"Fernandez, Dawn M., H. Adeeb, F. Rahman, Nicolas, Aleksey Fernandez, El-Ad David Chudnovskiy, Letizia Amir, Nayaab S. Amadori, and Khan et al. 2019. Single-cell immune landscape of human atherosclerotic plaques. Nature Medicine 25:1576\u20131588. https:\/\/doi.org\/10.1038\/s41591-019-0590-4","journal-title":"Nature Medicine"},{"key":"2485_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1161\/ATVBAHA.107.147827","volume":"28","author":"Eva J. A. van Wanrooij","year":"2008","unstructured":"van Wanrooij, Eva J. A.., Saskia C. A.. de Jager, Thomas van Es, Paula de Vos, Helen L.. Birch, David A.. Owen, Robbert J.. Watson, et al. 2008. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 28: 251\u2013257. https:\/\/doi.org\/10.1161\/ATVBAHA.107.147827.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2485_CR23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.jacc.2007.06.040","volume":"50","author":"Giovanna Liuzzo","year":"2007","unstructured":"Liuzzo, Giovanna, Luigi M.. Biasucci, Graziana Trotta, Salvatore Brugaletta, Michela Pinnelli, Giovanna Digianuario, Vittoria Rizzello, et al. 2007. Unusual CD4\u2009+\u2009CD28null T lymphocytes and recurrence of acute coronary events. Journal of the American College of Cardiology 50: 1450\u20131458. https:\/\/doi.org\/10.1016\/j.jacc.2007.06.040.","journal-title":"Journal of the American College of Cardiology"},{"key":"2485_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"E. John Wherry","year":"2015","unstructured":"Wherry, E. John., and Makoto Kurachi. 2015. Molecular and cellular insights into T cell exhaustion. Nature Reviews. Immunology 15: 486\u2013499. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nature Reviews. Immunology"},{"key":"2485_CR25","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.4049\/jimmunol.181.7.4832","volume":"181","author":"Kenneth J. Oestreich","year":"2008","unstructured":"Oestreich, Kenneth J.., Hyesuk Yoon, Rafi Ahmed, and Jeremy M.. Boss. 2008. NFATc1 regulates PD-1 expression upon T cell activation. Journal of Immunology (Baltimore, Md.\u202f: 1950) 181: 4832\u20134839. https:\/\/doi.org\/10.4049\/jimmunol.181.7.4832.","journal-title":"Journal of Immunology (Baltimore, Md. : 1950)"},{"key":"2485_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.immuni.2013.11.017","volume":"40","author":"Tetsuya Honda","year":"2014","unstructured":"Honda, Tetsuya, Jackson G.. Egen, Tim L\u00e4mmermann, Wolfgang Kastenm\u00fcller, Parizad Torabi-Parizi, and Ronald N.. Germain. 2014. Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity 40: 235\u2013247. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.017.","journal-title":"Immunity"},{"key":"2485_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ni.2762","volume":"14","author":"Taku Okazaki","year":"2013","unstructured":"Okazaki, Taku, Shunsuke Chikuma, Yoshiko Iwai, Sidonia Fagarasan, and Tasuku Honjo. 2013. A rheostat for immune responses: The unique properties of PD-1 and their advantages for clinical application. Nature Immunology 14: 1212\u20131218. https:\/\/doi.org\/10.1038\/ni.2762.","journal-title":"Nature Immunology"},{"key":"2485_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.intimp.2017.09.028","volume":"52","author":"Ru Ding","year":"2017","unstructured":"Ding, Ru., Wenwu Gao, Zhiqing He, Feng Wu, Yang Chu, Jie Wu, Lan Ma, and Chun Liang. 2017. Circulating CD4\u2009+\u2009CXCR5+ T cells contribute to proinflammatory responses in multiple ways in coronary artery disease. International Immunopharmacology 52: 318\u2013323. https:\/\/doi.org\/10.1016\/j.intimp.2017.09.028.","journal-title":"International Immunopharmacology"},{"key":"2485_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaccao.2020.08.007","volume":"2","author":"Kikkie Poels","year":"2020","unstructured":"Poels, Kikkie, Mandy M. T.. van Leent, Celine Boutros, Hubert Tissot, S\u00e9verine. Roy, Anu E.. Meerwaldt, Yohana C. A.. Toner, et al. 2020. Immune checkpoint inhibitor therapy aggravates T cell-driven plaque inflammation in atherosclerosis. JACC. CardioOncology 2: 599\u2013610. https:\/\/doi.org\/10.1016\/j.jaccao.2020.08.007.","journal-title":"JACC. CardioOncology"},{"key":"2485_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41422-024-00945-0","volume":"34","author":"Lin Fan","year":"2024","unstructured":"Fan, Lin, Junwei Liu, Wei Hu, Zexin Chen, Jie Lan, Tongtong Zhang, Yang Zhang, et al. 2024. Targeting pro-inflammatory T cells as a novel therapeutic approach to potentially resolve atherosclerosis in humans. Cell Research 34: 407\u2013427. https:\/\/doi.org\/10.1038\/s41422-024-00945-0.","journal-title":"Cell Research"},{"key":"2485_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrcardio.2009.228","volume":"7","author":"Kevin J. Woollard","year":"2010","unstructured":"Woollard, Kevin J.., and Frederic Geissmann. 2010. Monocytes in atherosclerosis: Subsets and functions. Nature Reviews. Cardiology 7: 77\u201386. https:\/\/doi.org\/10.1038\/nrcardio.2009.228.","journal-title":"Nature Reviews. Cardiology"},{"key":"2485_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/ar2390","volume":"10","author":"Fionula M. Brennan","year":"2008","unstructured":"Brennan, Fionula M.., Nicola M. G.. Smith, Sally Owen, Ching Li, Parisa Amjadi, Patricia Green, Anna Andersson, et al. 2008. Resting CD4\u2009+\u2009effector memory T cells are precursors of bystander-activated effectors: A surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Research & Therapy 10: R36. https:\/\/doi.org\/10.1186\/ar2390.","journal-title":"Arthritis Research & Therapy"},{"key":"2485_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03181-4","volume":"9","author":"Clare L. V. Westhorpe","year":"2018","unstructured":"Westhorpe, Clare L. V.., M. Ursula. Norman, Pam Hall, Sarah L.. Snelgrove, Michaela Finsterbusch, Anqi Li, Camden Lo, et al. 2018. Effector CD4\u2009+\u2009T cells recognize intravascular antigen presented by patrolling monocytes. Nature Communications 9: 747. https:\/\/doi.org\/10.1038\/s41467-018-03181-4.","journal-title":"Nature Communications"},{"key":"2485_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1161\/ATVBAHA.112.300930","volume":"33","author":"Lucie Poupel","year":"2013","unstructured":"Poupel, Lucie, Alexandre Boissonnas, Patricia Hermand, Karim Dorgham, Elodie Guyon, Constance Auvynet, Flora Saint Charles, Philippe Lesnik, Philippe Deterre, and Christophe Combadiere. 2013. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology 33: 2297\u20132305. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300930.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2485_CR35","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.2353\/ajpath.2006.051054","volume":"168","author":"Janet Chamberlain","year":"2006","unstructured":"Chamberlain, Janet, David Evans, Andrea King, Rachael Dewberry, Steven Dower, David Crossman, and Sheila Francis. 2006. Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. The American Journal of Pathology 168: 1396\u20131403. https:\/\/doi.org\/10.2353\/ajpath.2006.051054.","journal-title":"The American Journal of Pathology"},{"key":"2485_CR36","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1161\/01.atv.20.11.2394","volume":"20","author":"R Dewberry","year":"2000","unstructured":"Dewberry, R., H. Holden, D. Crossman, and S. Francis. 2000. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 2394\u20132400. https:\/\/doi.org\/10.1161\/01.atv.20.11.2394.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2485_CR37","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"Paul M. Ridker","year":"2017","unstructured":"Ridker, Paul M.., Brendan M.. Everett, Tom Thuren, Jean G.. MacFadyen, William H.. Chang, Christie Ballantyne, Francisco Fonseca, et al. 2017. Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine 377: 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914.","journal-title":"The New England Journal of Medicine"},{"key":"2485_CR38","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/s0300-8932(02)76693-1","volume":"55","author":"Ruth P\u00e9rez Fern\u00e1ndez","year":"2002","unstructured":"P\u00e9rez Fern\u00e1ndez, Ruth, and Juan Carlos Kaski. 2002. Interleukin-10 and coronary disease. Revista Espa\u00f1ola de Cardiolog\u00eda 55: 738\u2013750. https:\/\/doi.org\/10.1016\/s0300-8932(02)76693-1.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"key":"2485_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.896810","volume":"9","author":"Sheng Liu","year":"2022","unstructured":"Liu, Sheng, Chenyang Wang, Jinzhu Guo, Yunxiao Yang, Mengling Huang, Li. Li, Yu. Wang, Yanwen Qin, and Ming Zhang. 2022. Serum cytokines predict the severity of coronary artery disease without acute myocardial infarction. Frontiers in Cardiovascular Medicine 9: 896810. https:\/\/doi.org\/10.3389\/fcvm.2022.896810.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"2485_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21737-9","volume":"12","author":"Icia Santos-Zas","year":"2021","unstructured":"Santos-Zas, Icia, Jeremie Lemari\u00e9, Ivana Zlatanova, Marine Cachanado, Jean-Christophe. Seghezzi, Hakim Benamer, Pascal Goube, et al. 2021. Cytotoxic CD8\u2009+\u2009T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nature Communications 12: 1483. https:\/\/doi.org\/10.1038\/s41467-021-21737-9.","journal-title":"Nature Communications"},{"key":"2485_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/biom10111514","volume":"10","author":"Marko Kumri\u0107","year":"2020","unstructured":"Kumri\u0107, Marko, Tina Ti\u010dinovi\u0107 Kurir, Josip A.. Borovac, and Jo.\u0161ko Bo\u017ei\u0107. 2020. The role of natural killer (NK) cells in acute coronary syndrome: A comprehensive review. Biomolecules 10: 1514. https:\/\/doi.org\/10.3390\/biom10111514.","journal-title":"Biomolecules"},{"key":"2485_CR42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/cei.12210","volume":"175","author":"K Backteman","year":"2014","unstructured":"Backteman, K., J. Ernerudh, and L. Jonasson. 2014. Natural killer (NK) cell deficit in coronary artery disease: No aberrations in phenotype but sustained reduction of NK cells is associated with low-grade inflammation. Clinical and Experimental Immunology 175: 104\u2013112. https:\/\/doi.org\/10.1111\/cei.12210.","journal-title":"Clinical and Experimental Immunology"},{"key":"2485_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7150\/ijms.17119","volume":"14","author":"Wenwen Yan","year":"2017","unstructured":"Yan, Wenwen, Yanli Song, Lin Zhou, Jinfa Jiang, Fang Yang, Qianglin Duan, Lin Che, Yuqin Shen, Haoming Song, and Lemin Wang. 2017. Immune cell repertoire and their mediators in patients with acute myocardial infarction or stable angina pectoris. International Journal of Medical Sciences 14: 181\u2013190. https:\/\/doi.org\/10.7150\/ijms.17119.","journal-title":"International Journal of Medical Sciences"},{"key":"2485_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-3083.2011.02554.x","volume":"74","author":"G Laskarin","year":"2011","unstructured":"Laskarin, G., V. Persic, A. Ruzic, B. Miletic, M. Rakic, D. Travica Samsa, D. Raljevic, V. Pehar Pejcinovic, R. Miskulin, and D. Rukavina. 2011. Perforin-mediated cytotoxicity in non-ST elevation myocardial infarction. Scandinavian Journal of Immunology 74:195\u2013204. https:\/\/doi.org\/10.1111\/j.1365-3083.2011.02554.x","journal-title":"Scandinavian Journal of Immunology"},{"key":"2485_CR45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/j.1365-3083.2006.01816.x","volume":"64","author":"P Szodoray","year":"2006","unstructured":"Szodoray, P., O. Timar, K. Veres, H. Der, E. Szomjak, G. Lakos, M. Aleksza, B. Nakken, G. Szegedi, and P. Soltesz. 2006. TH1\/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines\u2013immunological alterations in acute coronary syndrome and stable coronary artery disease. Scandinavian Journal of Immunology 64:336\u2013344. https:\/\/doi.org\/10.1111\/j.1365-3083.2006.01816.x","journal-title":"Scandinavian Journal of Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02485-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:35:22Z","timestamp":1774571722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02485-8","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}